Atopic dermatitis-mitigating effects of new Lactobacillus strain, Lactobacillus sakei probio 65 isolated from Kimchi

Journal of Applied Microbiology

Volumn 115, Issue 2, 2013, Pages 517-526

  Kim, J Y ^a   Park, B K ^a   Park, H J ^a   Park, Y H ^b   Kim, B O ^c   Pyo, S ^a  

^a Sungkyunkwan University   (South Korea)

^b Yeungnam University   (South Korea)

^c Kyungpook National University   (South Korea)

Author keywords

Atopic dermatitis; Chemokine; Cytokine; IgE; Lactobacillus sakei

Indexed keywords

BODY FLUIDS; CHEMICAL ACTIVATION; DERMATITIS; DERMATOLOGY;

ATOPIC DERMATITIS; CHEMOKINES; CYTOKINES; IGE; INHIBITORY EFFECT; LACTOBACILLUS SAKEI; LACTOBACILLUS STRAINS; MITIGATING EFFECTS; SKIN DISEASE; SKIN LESION;

T-CELLS;

BETA N ACETYLHEXOSAMINIDASE; CUTANEOUS T CELL ATTRACTING CHEMOKINE; IMMUNOGLOBULIN E; INTERLEUKIN 4; INTERLEUKIN 6; PROBIOTIC AGENT; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA;

ALLERGY; BACTERIUM; DISEASE PREVALENCE; FREQUENCY ANALYSIS; IMMUNE RESPONSE; INHIBITION; INHIBITOR; RODENT;

ALLERGIC REACTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATOPIC DERMATITIS; BACTERIAL STRAIN; BACTERIUM ISOLATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; IMMUNOBLOTTING; IMMUNOGLOBULIN BLOOD LEVEL; IN VITRO STUDY; IN VIVO STUDY; LACTOBACILLUS SAKEI; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SCRATCHING; SKIN DEFECT;

LACTOBACILLUS; LACTOBACILLUS SAKEI; MUS;

EID: 84880604662     PISSN: 13645072     EISSN: 13652672     Source Type: Journal    
DOI: 10.1111/jam.12229     Document Type: Article

References (40)

1. Adams, C.A. (2010) The probiotic paradox: live and dead cells are biological response modifiers. Nutr Res Rev 23, 37-46.
2. Besselink, M.G., van Santvoort, H.C., Buskens, E., Boermeester, M.A., van Goor, H., Timmerman, H.M., Nieuwenhuijs, V.B., Bollen, T.L. et al. (2008) Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 371, 651-659.
3. Boyle, R.J., Robins-Browne, R.M. and Tang, M.L. (2006) Probiotic use in clinical practice: what are the risks? Am J Clin Nutr 83, 1256-1264.
4. Bradding, P., Roberts, J.A., Britten, K.M., Montefort, S., Djukanovic, R., Mueller, R., Heusser, C.H., Howarth, P.H. et al. (1994) Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 10, 471-480.
5. El-Feky, R.A. (2011) Mast cell and atopy. Egypt J Pediatr Allergy Immunol 9, 55-62.
6. Furrie, E. (2005) Probiotics and allergy. Proc Nutr Soc 64, 465-469.
7. Fyhrquist, N., Lehtimäki, S., Lahl, K., Savinko, T., Lappeteläinen, A.M., Sparwasser, T., Wolff, H., Lauerma, A. et al. (2012) Foxp3 + cells control Th2 responses in a murine model of atopic dermatitis. J Invest Dermatol 132, 1672-1680.
8. Gilfillan, A.M. and Tkaczyk, C. (2006) Integrated signalling pathways for mast-cell activation. Nat Rev Immunol 6, 218-230.
9. Gill, H.S. and Guarner, F. (2004) Probiotics and human health: a clinical perspective. Postgrad Med J 80, 516-526.
10. Han, E.H., Park, J.H., Kim, J.Y. and Jeong, H.G. (2009) Houttuynia cordata water extract suppresses anaphylactic reaction and IgE-mediated allergic response by inhibiting multiple steps of FcεRI signaling in mast cells. Food Chem Toxicol 47, 1659-1666.
11. Han, N.R., Moon, P.D., Kim, H.M. and Jeong, H.J. (2012) Effect of Pyeongwee-San (KMP6) on 2, 4-dinitrofluorobenzene-induced atopic dermatitis-like lesions in NC/Nga mice. Life Sci 90, 147-153.
12. Hijnen, D., De Bruin-Weller, M., Oosting, B., Lebre, C., De Jong, E., Bruijnzeel-Koomen, C. and Knol, E. (2004) Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis. J Allergy Clin Immunol 113, 334-340.
13. Homey, B., Steinhoff, M., Ruzicka, T. and Leung, D.Y. (2006) Cytokines and chemokines orchestrate atopic skin inflammation. J Allergy Clin Immunol 118, 178-189.
14. Imai, T., Nagira, M., Takagi, S., Kakizaki, M., Nishimura, M., Wang, J., Gray, P.W., Matsushima, K. et al. (1999) Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol 11, 81-88.
15. Jin, H., He, R., Oyoshi, M. and Geha, R.S. (2009) Animal models of atopic dermatitis. J Invest Dermatol 129, 31-40.
16. Joo, S.S., Kim, S.G., Choi, S.E., Kim, Y., Park, H.Y., Seo, S.J., Choi, Y.W., Lee, M.W. et al. (2009) Suppression of T cell activation by hirsutenone, isolated from the bark of Alnus japonica, and its therapeutic advantages for atopic dermatitis. Eur J Pharmacol 614, 98-105.
17. Kakinuma, T., Nakamura, K., Wakugawa, M., Mitsui, H., Tada, Y., Saeki, H., Torii, H., Asahina, A. et al. (2001) Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 107, 535-541.
18. Kakinuma, T., Saeki, H., Tsunemi, Y., Fujita, H., Asano, N., Mitsui, H., Tada, Y., Wakugawa, M. et al. (2003) Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris. J Allergy Clin Immunol 111, 592-597.
19. Kang, J.S., Youm, J., Jeong, S.K., Park, B.D., Yoon, W.K., Han, M.H., Lee, H., Han, S.B. et al. (2007) Topical application of a novel ceramide derivative, K6PC-9, inhibits dust mite extract-induced atopic dermatitis-like skin lesions in NC/Nga mice. Int Immunopharmacol 7, 1589-1597.
20. Karki, R., Jung, M., Kim, K. and Kim, D. (2012) Inhibitory effect of Nelumbo nucifera (Gaertn.) on the development of atopic dermatitis-like skin lesions in NC/Nga mice. Evid Based Complement Alternat Med 2012, 153568.
21. Kataria, J., Li, N., Wynn, J.L. and Neu, J. (2009) Probiotic microbes: do they need to be alive to be beneficial? Nutr Rev 67, 546-550.
22. Kirjavainen, P.V., Salminen, S.J. and Isolauri, E. (2003) Probiotic bacteria in the management of atopic disease: underscoring the importance of viability. J Pediatr Gastroenterol Nutr 36, 223-227.
23. Krüger-Krasagakes, S., Möller, A., Kolde, G., Lippert, U., Weber, M. and Henz, B.M. (1996) Production of interleukin-6 by human mast cells and basophilic cells. J Invest Dermatol 106, 75-79.
24. Larché, M. (2007) Regulatory T cells in allergy and asthma. Chest 132, 1007-1014.
25. Lee, J.H. and Cho, S.H. (2011) Korean red ginseng extract ameliorates skin lesions in NC/Nga mice: an atopic dermatitis model. J Ethnopharmacol 133, 810-817.
26. Leung, D.Y. and Bieber, T. (2003) Atopic dermatitis. Lancet 361, 151-160.
27. Lin, W., Truong, N., Grossman, W.J., Haribhai, D., Williams, C.B., Wang, J., Martín, M.G. and Chatila, T.A. (2005) Allergic dysregulation and hyperimmunoglobulinemia E in Foxp3 mutant mice. J Allergy Clin Immunol 116, 1106-1115.
28. Matricardi, P.M., Bjotksten, B., Bonini, S., Bousquet, J., Djukkanovic, R., Dreborg, S., Gereda, J., Malling, H.J. et al. (2003) Microbial products in allergy prevention and therapy. Allergy 58, 461-471.
29. Mihara, K., Kuratani, K., Matsui, T., Nakamura, M. and Yokota, K. (2004) Vital role of the Itch-scratch response in development of spontaneous dermatitis in NC/Nga mice. Br J Dermatol 151, 335-345.
30. Nakazato, J., Kishida, M., Kuroiwa, R., Fujiwara, J., Shimoda, M. and Shinomiya, N. (2008) Serum levels of Th2 chemokines, CCL17, CCL22, and CCL27, were the important markers of severity in infantile atopic dermatitis. Pediatr Allergy Immunol 19, 605-613.
31. Park, C.W., Youn, M., Jung, Y., Kim, H., Jeong, Y., Lee, H.K., Kim, H.O., Lee, I. et al. (2008) New functional probiotic Lactobacillus sakei probio 65 alleviates atopic symptoms in the mouse. J Med Food 11, 405-412.
32. Prescott, S.L. and Björkstén, B. (2007) Probiotics for the prevention or treatment of allergic diseases. J Allergy Clin Immunol 120, 255-262.
33. Romagnani, S. (1991) Type 1 T helper and type 2 T helper cells: functions, regulation and role in protection and disease. Int J Clin Lab Res 21, 152-158.
34. Ständer, S. and Steinhoff, M. (2002) Pathophysiology of pruritus in atopic dermatitis: an overview. Exp Dermatol 11, 12-24.
35. Van Och, F.M., Van Loveren, H., De Jong, W.H. and Vandebriel, R.J. (2002) Cytokine production induced by low-molecular-weight chemicals as a function of the stimulation index in a modified local lymph node assay: an approach to discriminate contact sensitizers from respiratory sensitizers. Toxicol Appl Pharmacol 184, 46-56.
36. Vestergaard, C., Yoneyama, H., Murai, M., Nakamura, K., Tamaki, K., Terashima, Y., Imai, T., Yoshie, O. et al. (1999) Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J Clin Invest 104, 1097-1105.
37. Woo, S., Kim, J., Lee, Y., Kim, N. and Hahn, Y. (2010) Effect of Lactobacillus sakei supplementation in children with atopic eczema-dermatitis syndrome. Ann Allergy Asthma Immunol 104, 343-348.
38. Yun, J.W., Kim, H., Kang, H.J., Koh, J.Y. and Kim, B.H. (2008) Comparative evaluation of animal models for atopic dermatitis in NC/Nga mice. Lab Anim Res 24, 59-66.
39. Yun, M.Y., Yang, J.H., Kim, D.K., Cheong, K.J., Song, H.H., Kim, D.H., Cheong, K.J., Kim, Y.I. et al. (2010) Therapeutic effects of Baicalein on atopic dermatitis-like skin lesions of NC/Nga mice induced by Dermatophagoides pteronyssinus. Int Immunopharmacol 10, 1142-1148.
40. Zheng, H., Jeong, Y., Song, J. and Ji, G.E. (2011) Oral administration of ginsenoside Rh1 inhibits the development of atopic dermatitis-like skin lesions induced by oxazolone in hairless mice. Int Immunopharmacol 11, 511-518.